$BCLI | Nirvana Systems Inc.

Tag Archives for " $BCLI "

BCLI: Manufacturing Agreement with Catalent; Recent Sell-off Unwarranted…

By David Bautz, PhD NASDAQ:BCLI READ THE FULL BCLI RESEARCH REPORT Business Update Manufacturing Agreement with Catalent On October 22, 2020, BrainStorm Cell Therapeutics, Inc. (NASDAQ:BCLI) announced an agreement with Catalent, Inc. (CTLT) for the manufacture of NurOwn®, which is currently being evaluated in a Phase 3 clinical trial in patients with amyotrophic lateral sclerosis (ALS). The agreement calls for Catalent to produce cGMP clinical supply of NurOwn at its new 32,000 square foot cell therapy manufacturing facility in Houston, TX. Upon FDA approval of NurOwn, we anticipate the companies extending the agreement to include production of commercial supplies of NurOwn from the same facility.

Continue reading
>